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INTRODUCTION 
IN THE nine years since HEATH and his associates1 reported their findings on taraxein, 
numerous other laboratories have sought confirmation of the presence of an abnormality 
unique to the blood of schizophrenic patients. Germane to this research have been attempts 
to demonstrate behavioral deficits in animals given various blood constituents from schizo- 
phrenics. To date, results of such research are equivocal. WINTER and FLATTAKER% and 
BERGEN et al.3 have obtained evidence of a substance in the blood of schizophrenics which 
increases response time of rats trained to perform a positively rewarded instrumental 
response. BISHOPS has reported plasma from schizophrenic patients depresses learning of a 
conditioned avoidance response in rats. The literature is however, replete with reports 
failing to substantiate the existence of a factor unique to the blood of schizophrenics 
capable of affecting behavior.s-* 
Failure to show evidence of a behavioral impairment in animals following the injection of 
plasma of schizophrenic patients may reflect the use of inappropriate test procedures, 
subject number, subject selection, analysis procedures or any of the other sundry criticisms 
frequently leveled at negative data. Although general agreement exists among investigators 
with regard to an adequate use of most of these parameters, considerable variation appears 
to exist as to what constitutes an appropriate behavioral measure for screening plasma from 
schizophrenics. In large part, the use of one assessment technique, to the exclusion of another, 
reflects largely the desire to use a measure proven reliable in one’s laboratory. BISHOP9 has 
raised the important question of test validity as it relates to measures of learning used to 
assay the behavioral effects of plasma. The decision of many investigators to use learning 
measures appears motivated by laboratory studies at the human level of the effects of 
schizophrenia upon learning performance. MEDNICK~~ concluded that schizophrenic patients 
are superior to normal subjects for tasks of: low complexity (e.g. classical conditioning), 
the reverse being true as task complexity increases. BISHOPS has hypothesized that demon- 
strations of an agent in the plasma of schizophrenic patients capable of impairing behavior 
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might favor use of a ‘complex’ animal task in preference to simple learning measures. 
Bishop suggests that for measures of learning, acquisition would represent a more complex 
phase than the retention or later phase of task performance and thus would be a more 
valid index of plasma effects. To date, such a distinction appears unwarranted in light of the 
reports by BERGEN et n1.,s and BISHOPS which show evidence for a behavioral deficit following 
the injection of plasma in rats and measured for retention and acquisition of a learning 
task, respectively. It should be further noted that type of reinforcement (viz. positive or 
negative) appears to be of minor importance in view of the findings of Bergen et al. and 
Bishop for approach and avoidance learning. 
One point concerning task complexity deserves closer scrutiny. Bergen et al. report that 
plasma from all schizophrenics tested by them depressed performance on their task. These 
data are in contrast to those of BISHOPS who reported that while grouped data demonstrated 
learning impairment for rats administered plasma from schizophrenic patients, approxi- 
mately 33 per cent of the schizophrenic donor’s plasma produced faster learning when 
compared to animals injected with normal plasma. It remains to be answered whether the 
difference between these two studies is attributable to the degree of purity of the plasma 
injected (viz. purified plasma fractions in the Bergen et al. study and unfractionated 
plasma for the Bishop study), the discriminative power of the respective tests or some, as 
yet, unknown parameter. Such an unknown parameter may be the degree of universality 
of a blood metabolite in plasma from schizophrenics capable of impairing animal behavior. 
Specifically, the hypothesis might be advanced that any blood metabolite in plasma 
from schizophrenic patients capable of impairing animal behavior may not be universally 
present in the schizophrenic population. Thus, success or failure to demonstrate a ‘psycho- 
toxic’ effect in animals administered schizophrenic plasma may resolve itself to a problem 
based on the selection of the patients being tested. The feasibility of such a hypothesis 
would be greatly enhanced if independent psychometric or biometric measures could 
clearly subdivide a population of schizophrenic patients. 
The present investigation was designed as a preliminary test of the effect of blood plasma 
from schizophrenic patients on acquisition of a conditioned avoidance response in rats. 
Donors for this research were a group of chronic schizophrenic patients from the Lafayette 
Clinic research ward and housed at Northville State Hospital. Although these patients 
appear to be clinically homogeneous, they have been found to be differentiable into two 
discernable subgroups based on several biometric criteria (GOTTLIEB~~). This paper describes 
the results of research aimed at the question of the importance of such a distinction for 
studies of ‘psychotoxicity’ of the plasma from schizophrenics. It is not the intent of this 
research to validate, by the use of behavioral techniques, the differences found to exist 
between these subgroups for the various measures listed here; but instead to utilize this sub- 
grouping, based on divergent tests, as possible criteria for testing our hypothesis. 
Selection of schizophrenic donors 
METHOD 
The criteria for diagnosis of chronic schizophrenia in patients used in this study have 
been previously described by CRANDALL et al. 13 All patients tested were from Northville 
State Hospital and housed in a special research ward under supervision of the Lafayette 
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Clinic and received a controlled adequate diet and daily vitamin supplements. All patients 
were free of drugs for at least 12 months with the exception of moderate daily amounts of 
cofie and cigarettes. Duration of hospitalization ranged from a minimum of four years-to a 
maximum of fifteen years. 
One group of these patients (N = 6) have been found to approach the scores of normal 
control subjects for the following measures : (a) GSR conditioning, (b) weight discrimination 
ability, (c) computer averaged photic evoked responses, (d) measures of work output and (e) 
lactate : pyruvate ratios in chicken erythrocytes following incubation in patients’ plasma. 
Schizophrenics in this group have been labelled subgroup A for convenience in discussion. 
The second group (N = 6) from this population performed for these tasks when compared 
to normals and subgroup A schizophrenics as follows : (a) less GSR conditioning, (b) poorer 
weight discrimination ability, (c) lower amplitude and shorter latency of photic evoked 
responses, (d) lower work output, and (e) higher lactate to pyruvate ratios in plasma-in- 
cubated chicken erythrocytes. We have labelled these patients subgroup B. Two other 
tests provided evidence for the division of these schizophrenics into subgroups, although the 
direction of change differed from the other measures. Subgroup A subjects showed a 
decreased energy content in the EEG upon frequency analysis with photic stimulation 
when compared to controls, whereas subgroup B subjects had an increased energy content. 
Furthermore, subgroup A subjects manifested a reduced amount of electroencephalographic 
stage I-REM sleep when compared to either subgroup B or control subjects. Reference 
made earlier to the clinical similarity between these subgroups, is based on an analysis of 
seventy-four clinical ratings of course of illness, mental status, symptomatology, and 
family history conducted on these patients. To date, no clinical variable has been found to 
clearly and consistently distinguish between these subgroups. 
Normal control donors (N = 6) in good physical health were selected from volunteers 
from the laboratory staffs of the Lafayette Clinic. 
Blood was drawn from patients and controls in the morning before breakfast, centrifuged 
at room temperature and refrigerated at 4°C. within 3-l h following collection. It remained 
there until used for either the morning (l-3 h post withdrawal) or afternoon (7-9 h post 
withdrawal) injections. 
Testing procedures 
Seventy male Sprague-Dawley rats weighing between 106 and 200 g served as subjects. 
Animals were allowed food and water ad libitum. Six experimental treatments were con- 
ducted in the morning and replicated on different subjects in the afternoon to control for 
time of testing variations in animal behavior. In all, twelve groups of animals were studied. 
The following six treatments were given: (a) subgroup A schizophrenics’ plasma, (b) sub- 
group B schizophrenics’ plasma, (c) normal plasma, (d) isotonic saline with 0.5% 
heparin, (e) reconstituted irradiated plasma, and (f) no injection. Plasma from each donor 
as well as the control solutions were given intraperitoneally. Morning tests were accom- 
plished between the hours of 8 and 10 a.m., afternoon tests between 2 and 4 p.m. Rats were 
given plasma in an amount equivalent to 10 ml/kg body weight. Each S remained in the test 
apparatus for 5 min following the injection and then was tested for acquisition of the pole 
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jump response. A modification of the test procedure of COOK and WEIDLEY~~ was used. The 
pole jump apparatus consisted of a box 9 in. x 9 in. x 21 in. with a grid floor. A pole 
extended from the top of the box to within three inches of the center of the floor. The pole 
was of metal la in. in diameter allowing the S to slide off easily at the termination of a 
jump response. The grid floor was connected to a 60 c/s, 1 mA shock source supplied 
through a Foringer grid-shock scrambler. Illumination was provided by a 25 W bulb. 
The entire test apparatus was sound damped with a one-way-vision screen. The conditioned 
stimulus (CS) was a door buzzer of 5 s duration and was followed by and overlapped with an 
electric shock unconditioned stimulus (US) of 10 s duration. A random intertrial interval 
of 30 s mean duration was utilized under massed training conditions. A criterion of 9 out 
of 10 avoidance responses (i.e. pole jump only during the CS interval) was utilized. Testing 
was terminated if criterion was not achieved in 100 trials, and the number of trials recorded 
as 100. 
RESULTS 
Data were combined for morning and afternoon test sessions for each of the six experi- 
mental treatments when statistical analyses failed to show significant differences for this 
variable. It was worthy of note however, that subjects tested in the afternoon which received 
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FIG. 1. Mean trials to criterion (f 1 standard deviation) for plasma and nonplasma injected 
groups on the pole jump test for a.m. and p.m. test sessions. 
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approximately ten trials less than the other groups tested in the morning. Figure 1 presents 
these data for all experimental treatments. Failure to observe any marked performance 
differences for morning versus afternoon tests for the nonplasma groups indicates the 
absence of any confounding effect for time of testing (i.e. morning vs. afternoon replication). 
Furthermore, this observation suggests that time between withdrawal and injection of 
plasma (i.e. age of plasma post withdrawal) is a variable capable of affecting a behavioral 
change. Similarly, no significant differences were obtained between groups which received 
normal, reconstituted, or schizophrenic plasma (i.e. combined data for schizophrenic sub- 
groups A and B), nor were differences observed between the saline-heparin and no injection 
groups. Data from the saline-heparin and no injection groups were combined to form a 
nonplasma group (N = 24) for purposes of subsequent comparisons. A test of the behavioral 
effects of plasma revealed that the normal, reconstituted, and combined schizophrenic 
plasma groups were all significantly slower in attaining performance criterion when com- 
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FIG. 2. Comparison of combined a.m. and p.m. data for plasma and nonplasma injections on 
mean trials to criterion (& 1 standard deviation). 
pared to the nonplasma group (p CO-002; p <O-O02 and p <0.003, respectively for the 
Mann-Whitney U test for nonparametric data). Figure 2 presents performance data for the 
plasma and combined nonplasma groups. A comparison of all plasma regardless of source 
(Y = 8169, N = 46) to nonplasma (2 = 46.62, N = 24) was highly significant (p <O.OOl). 
Next, the data for schizophrenic subgroups A (x = 56.92, N = 12) and B (B = 90.50, 
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N = 12) were compared, and each compared separately to the normal (2 = 95.08, N = 12), 
reconstituted ( 8= 84.80, N = lo), and nonplasma treatments (8 = 46.62, N = 24). 
Table 1 presents the p values (Mann-Whitney two-tailed U-test) computed for these com- 
parisons. It may be seen that animals treated with plasma from schizophrenic subgroup B 
responded similarly to subjects given normal or reconstituted plasma but, were significantly 
TABLE 1. PROBABILITIES ATTACHED TO TWO GROUP COMPARISONS FOR PLASMA ND NONPLASMA 
TREATMENTS USING THE MANN-WHITNEY U-TEST FOR NON PARAMETRIC DATA 
Schizophrenic plasma 
Substance injected Subgroup A Subgroup B 
(N = 12) (N = 12) 
Normal plasma (N = 12) vs. ( p CO.002” N.S. 
Reconstituted plasma (N = 10) vs. (p co.05 N.S. 
Non plasma (N = 24) vs. ( N.S.? p <0.002 
Subgroup A vs. Subgroup B p <0.02 
* Two-tail Mann-Whitney U-test. 
t Nonsignificant for p _( 0.10, two-tail Mann-Whitney U-test. 
slower learners than animals receiving plasma from subgroup A and the nonplasma controls. 
These results are in sharp contrast to the performance of animals given plasma from sub- 
group A who differed significantly from both the normal and reconstituted plasma-treated 
animals, but not from the nonplasma group. 
DISCUSSION 
The results of this investigation clearly point to a disturbance in rate of learning an 
avoidance task following the intraperitoneal injection of human plasma. Obviously the site 
of action for the detrimental effects of human plasma needs to be established. It may well 
be a local gastrointestinal irritation or any of sundry other causes arising from the injection 
of a foreign protein or other organic or inorganic substances. The possibility of a direct 
central action remains, but must be established in future research. It appears to matter 
little whether such plasma is of long standing or freshly drawn. Furthermore, it would seem, 
at first glance, that the distinction between normal, reconstituted, or non-subgrouped 
schizophrenic plasma is not important, for all produced a behavioral effect. However, when, 
in the present investigation, the schizophrenic group was differentiated into two sub; 
groups based on previous studies,11 a striking finding was that plasma from one group 
lacked apparent signs of impairing learning rate when compared to a saline control group 
or subjects receiving no injection; whereas, plasma from the other subgroup was virtually 
indistinguishable in the degree to which it depressed behavior from that of normal or 
reconstituted plasma. This study is in agreement with the findings of BISHOP9 for a differential 
performance in rats given plasma from clinically similar schizophrenics and with GERARD~~ 
insomuch as it indicates a likelihood of biologic subgroups of schizophrenics. Perhaps, as 
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stated earlier, some of the data in the literature dealing with toxic factors in the blood of 
schizophrenic patients may be related to this finding. 
Whether the failure to observe a learning deficit in rats given the plasma of schizophrenic 
subgroup A arises from the presence of some blood factor which negates a normally 
‘psychotoxic’ plasma effect or whether their blood lacks some substance which normally 
affects learning behavior, are only two of numerous possibilities which remain to be 
investigated. There is little doubt, however, that the learning deficit produced by plasma 
from subgroup B is not directly related to the biochemical factor responsible for the change 
in the lactate to pyruvate ratio as outlined by FROHMAN et a1.isJ6 First, the plasma factor 
described by Frohman is almost completely destroyed within 3 h on standing at 4°C. In 
the present investigation, the plasma from schizophrenic patients was injected between one 
and nine hours after withdrawal. Although it was refrigerated most of the time at 4”C., 
about 1 h elapsed prior to the first injections during which it was at or near room temperature. 
Although some evidence for the loss of a behavioral effect was noted in all three plasma 
groups by the decrease in trials to criterion for the afternoon versus morning groups, it 
should be emphasized that this change was observed for all three plasma groups and not 
exclusively for the schizophrenic subjects. Second, plasma from group B donors, which 
reportedly contain the factor described by FROHMAN, did not produce a significantly 
greater difference for mean trials to criterion for the pole jumping test when compared to 
normal plasma. 
One final point deserves mention. It may be noted in this paper for several of the be- 
havioral tests applied to the two schizophrenic subgroups at the Lafayette Clinic and des- 
cribed earlier,11 subgroup A patients behaved similarly to the behavior reported for normal 
subjects receiving amphetamine-like substances, whereas performance of subgroup B 
patients was more like that of a group of normals given sedative-like substances. The 
present data appear to further support this point. Subgroup A plasma injected rats achieved 
criterion performance in fewer trials than subgroup B subjects. DOMINO, CALD\NELL, and 
HENKE~~ have reported increased speed in learning the pole jump response following 
administration of amphetamine to rats, whereas, decreased learning rates were found to 
follow the administration of sedatives or psychotomimetics. Although the possible existence 
of such substances in human plasma is beyond the scope of the present research, the degree 
of correspondence seem worthy of note. 
A note of caution is in order regarding the failure to differentiate the normal, reconstituted 
and subgroup B treatments. By utilizing the restriction whereby training trials were ter- 
minated if the criterion had not been attained in one hundred trials, these groups may have 
been erroneously made to appear identical. If increased training trials had been administered, 
these groups may have differed. However, it should be noted from Fig. 1 for the afternoon 
replication, all groups achieved criterion performance at this time with the differences 
between the normal, reconstituted, and subgroup B treatment not significant. 
SUMMARY 
The effects of plasma from normal subjects and chronic schizophrenic patients were 
determined on the rate of learning a pole jump response in rats. The animals were trained to 
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a buzzer CS and electroshock US. Mean trials to a 90 per cent avoidance criterion were 
determined using a 100 trial cut off. Plasma and other control solutions were given intra- 
peritoneally in the morning and the procedure repeated in the afternoon with separate 
groups of rats. Test trials were initiated five minutes after injection. It was found that all 
plasma, in contrast to saline, produced an increase in the number of trials to learn the 
avoidance response. No d@erence in behavioral eflects was noted comparing the plasma of all 
chronic schizophrenics to normals. However, within the chronic schizophrenic population 
‘there are subgroups whose plasma was differentially effective in reducing rate of learning. 
These results are preliminary and subject to continued experimentation. They are presented 
here to make others aware of the need to consider the existence of possible biologic sub- 
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